Compare Flux Power Holdings Inc (FLUX) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Flux Power Holdings Inc trades at $0.6 (market cap $11.23M), while State Street SPDR S&P Biotech ETF trades at $159.13. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Flux Power Holdings Inc nearer its low. Which is the better fit depends on your goals.
| FLUX | XBI | |
|---|---|---|
Market Cap | $11.23M | — |
Sector | Utilities | Broad Market / Factor |
52-Week High | $6.66 | $164.28 |
52-Week Low | $0.51 | $86.92 |
Enterprise Value | $17.39M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX stock surged 17.58% to $0.6161, showing strong daily momentum despite a bearish technical backdrop with 17 sell signals. The company reported mixed quarterly earnings, missing estimates in Q3 2025 and Q1 2026 but beating in Q4 2025. Revenue declined to $51M in 2026 from $66M in 2025, with a net income margin of -12.48%. Recent developments include the launch of SkyEMS 3.0 AI platform and a new VP of Sales appointment, aiming to bolster growth in the energy storage sector.
Outlook is cautiously optimistic due to unanimous analyst buy ratings but tempered by profitability challenges and technical weakness. Key opportunities lie in AI-driven fleet solutions expansion, while risks include persistent losses, competitive pressure, and execution hurdles in scaling operations.
XBI trades at $158.81, up 0.49% today, with a bullish technical signal supported by moving averages. The ETF shows strong momentum with a 17% monthly gain and 75% annual return, driven by biotech sector strength. Analyst coverage is limited to one hold rating, while recent news highlights institutional buying interest and positive sector developments including M&A activity and drug trial successes.
The outlook remains positive given biotech's breakout from multi-year bear markets, though elevated volatility and policy risks persist. Key opportunities include AI-driven drug discovery and sustained M&A momentum, while risks involve sector-specific volatility and regulatory uncertainty. The ETF's equal-weight approach provides diversified exposure to biotech innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
